Brookstone Capital Management’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Sell
29,903
-849
-3% -$21.4K 0.01% 800
2026
Q1
$779K Sell
30,752
-302
-1% -$7.68K 0.01% 719
2025
Q4
$790K Sell
31,054
-715
-2% -$18.2K 0.01% 705
2025
Q3
$811K Buy
31,769
+1,487
+5% +$37.8K 0.01% 668
2025
Q2
$770K Buy
30,282
+2
+0% +$50 0.01% 635
2025
Q1
$765K Buy
30,280
+890
+3% +$22.3K 0.01% 614
2024
Q4
$732K Buy
29,390
+5,162
+21% +$130K 0.01% 603
2024
Q3
$619K Buy
24,228
+6,981
+40% +$176K 0.01% 637
2024
Q2
$431K Buy
17,247
+4,968
+40% +$122K 0.01% 689
2024
Q1
$306K Buy
+12,279
New +$306K 0.01% 757

Other funds holding IBDT

Brookstone Capital Management's IBDT Position: Q2 2026 in Review

Brookstone Capital Management reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 2.8% in Q2 2026, selling an estimated $21.4K and leaving 29,903 shares worth $755K. The position accounts for 0.01% of the portfolio, ranked #800.

Brookstone Capital Management first reported a position in IBDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $811K in Q3 2025. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Brookstone Capital Management held 29,903 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $755K as of Q2 2026.
  • Brookstone Capital Management sold 849 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $21.4K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #800 holding.
  • Brookstone Capital Management first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Brookstone Capital Management's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $811K in Q3 2025.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.